Evidence map›Paper›PMID 38200386›Full record

ArticleAnnals of surgical oncology2024

ASO Author Reflections: Pseudomyxoma Peritonei of Ovarian Origin-Modern Approach and Perspectives.

Alexis Trecourt, Naoual Bakrin, Olivier Glehen, Witold Gertych, Laurent Villeneuve, Vahan Kepenekian, Mojgan Devouassoux-Shisheboran, RENAPE Group

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexis TrecourtHospices Civils de Lyon, Hôpital Lyon Sud, Service de Pathologie, Lyon, France.
Naoual BakrinUR3738 - Centre pour l'Innovation en Cancérologie de Lyon (CICLY), Université Claude Bernard Lyon 1, Lyon, France.
Olivier GlehenUR3738 - Centre pour l'Innovation en Cancérologie de Lyon (CICLY), Université Claude Bernard Lyon 1, Lyon, France.
Witold GertychUR3738 - Centre pour l'Innovation en Cancérologie de Lyon (CICLY), Université Claude Bernard Lyon 1, Lyon, France.
Laurent VilleneuveUR3738 - Centre pour l'Innovation en Cancérologie de Lyon (CICLY), Université Claude Bernard Lyon 1, Lyon, France.
Vahan Kepenekian *UR3738 - Centre pour l'Innovation en Cancérologie de Lyon (CICLY), Université Claude Bernard Lyon 1, Lyon, France.
Mojgan Devouassoux-Shisheboran *Hospices Civils de Lyon, Hôpital Lyon Sud, Service de Pathologie, Lyon, France. mojgan.devouassoux@chu-lyon.fr.
RENAPE Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Appendiceal NeoplasmsOvarian NeoplasmsPeritoneal NeoplasmsPseudomyxoma PeritoneiFemaleHumansOvary

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.